QIAGEN Reports Preliminary Q3 Net Sales Of $548M; Preliminary Q3 Adj EPS $0.65; Co. Suspends FY 2026 Outlook While Transaction With EQT Private Equity Is Pending

Benzinga · 2d ago

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted earnings per share (EPS) were $0.65, also $0.65 CER.

QIAGEN plans to report full Q3 2026 results on Wednesday, November 4, 2026, at approximately 22:05 Frankfurt time / 16:05 New York time.

Given the announced transaction with EQT Private Equity, QIAGEN has suspended its full-year 2026 outlook while the transaction is pending. QIAGEN will also not hold a conference call for its Q3 2026 results.